missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD53 Polyclonal Antibody

Description
Immunogen sequence: AILLFVYEQK LNEYVAKGLT DSIHRYHSDN STKAAWDSIQ SFLQCCGING TSDWTSGPPA SCPSDRKVEG CYAKARLWFH S; Positive Samples: B cells, Jurkat, Raji, HL-60, Mouse liver, Mouse spleen, Mouse lung; Cellular Location: Cell junction, Cell membrane, Membrane, Multi-pass membrane protein.
CD53 is a tetraspanin family transmembrane glycoprotein expressed in the lymphoid-myeloid lineage. This molecule has been reported to form complexes with other leukocyte surface proteins such as CD2, CD19, CD21, MHC II, VLA-4 or tetraspanins CD37, CD81 and CD82, thus probably modulating various signaling processes. CD53 is involved in radioresistancy of tumor cells and its triggering has anti-apoptotic effect. In thymus, CD53 is up-regulated in response to positive selection signals during T cell development, and is strongly expressed upon macrophage exposure to bacterial lipopolysaccharide, whereas stimulation of neutrophils results in down-regulation of CD53 expression.
Specifications
Specifications
| Antigen | CD53 |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Concentration | 1.09 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.02% sodium azide; pH 7.3 |
| Gene | Cd53 |
| Gene Accession No. | P19397, Q61451 |
| Gene Alias | AI323659; antigen MOX44 identified by monoclonal antibody MRC-OX44; Cd53; CD53 antigen; CD53 glycoprotein; CD53 molecule; CD53 tetraspan antigen; cell surface antigen; cell surface glycoprotein CD53; Leukocyte antigen MRC OX-44; leukocyte surface antigen CD53; MOX44; OX44; Ox-44; tetraspanin-25; transmembrane glycoprotein; TSPAN25; tspan-25 |
| Gene Symbols | Cd53 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?